Note 19 – Earnings (Loss) Per Share

 

The net income (loss) available to common stockholders and weighted average common shares outstanding are as follows:

 

 

 

Year Ended
December 31,

 

 

 

2025

 

 

2024

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

Net income (loss)

 

$

38,104

 

 

$

(75,817

)

Accretion of financing fees

 

 

-

 

 

 

(1,954

)

Accrued dividends on Series C Preferred Stock

 

 

-

 

 

 

(18,227

)

Allocation of undistributed earnings to nonvested restricted shares

 

 

(1,242

)

 

 

-

 

Net income (loss) available to common stockholders - basic

 

$

36,862

 

 

$

(95,998

)

Undistributed earnings reallocated to nonvested restricted shares

 

 

70

 

 

 

-

 

Net income (loss) available to common stockholders - diluted

 

$

36,932

 

 

$

(95,998

)

Denominator:

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

18,009,667

 

 

 

17,495,542

 

Issuance of Warrants

 

 

13,796,337

 

 

 

13,231,374

 

Weighted average common shares outstanding - basic

 

 

31,806,004

 

 

 

30,726,916

 

Issuance of Fixed Warrants

 

 

972,587

 

 

 

-

 

Dilutive effect of employee stock options

 

 

1,009,872

 

 

 

-

 

Weighted average common shares outstanding - diluted

 

 

33,788,463

 

 

 

30,726,916

 

 

The Company computes earnings per share using the two-class method, which is an earnings allocation formula that determines earnings per share for Common Stock and participating securities. The Company’s participating securities are its grants of restricted stock which contain non-forfeitable rights to dividends. The Company allocates earnings between both classes; however, in periods of undistributed losses, they are only allocated to common shares as the unvested restricted stockholders do not contractually participate in losses of the Company. The Company computes basic earnings per share by dividing net income allocated to common shareholders by the weighted average number of shares outstanding during the year. Warrants issued in connection with the Company's long-term debt were issued at a nominal exercise price and are considered outstanding at the date of issuance. The 2023 Warrant was issued out-of-the money and the Company will apply the treasury stock method to the 2023 Warrant when computing earnings per share. Diluted earnings per share is calculated to give effect to all potentially dilutive common shares that were outstanding during the year. Weighted average diluted common shares outstanding include the incremental shares that would be issued upon the assumed exercise of stock options and the assumed vesting of non-vested share awards. For the years ended December 31, 2025 and 2024, 2,253,812 and 2,029,134 shares, respectively, were not included in the weighted average common shares outstanding calculation as they were anti-dilutive.

 

Shareholder Rights Plan

 

On September 2, 2025, the Company’s Board of Directors declared a dividend of one preferred share purchase right (a “Right”), payable on September 8, 2025, for each outstanding share of the Company’s common stock to stockholders of record on September 2, 2025. Each Right entitles the shareholder to purchase from the Company one one-hundredth of a share of Series D Junior Participating Preferred Stock for $42.00, once the Rights become exercisable, subject to adjustment.

The Rights will initially trade with and will be inseparable from common stock. The Rights will not be exercisable until: i) 10 business days after the public announcement that a person or group has become an “Acquiring Person” by obtaining beneficial ownership of 15% or more of the Company’s outstanding common stock (or 20% or more in the case of a person or group that is entitled to file, and does file, a Schedule 13G (a “13G Investor”)); or ii) 10 business days after a person or group begins or announces a tender or exchange offer which, if completed, would result in that person or group becoming an Acquiring Person. The Rights will expire on August 5, 2026, unless the Expiration Date is advanced or extended or unless the Rights are earlier redeemed or exchanged by the Company.

Historical Timeline

Fiscal YearFiled
2025Mar 9, 2026Showing above
2024Mar 12, 2025
2023Mar 18, 2024
2022Mar 27, 2023
2021Mar 22, 2022
2020Mar 24, 2021
2019Mar 4, 2020
2018Mar 4, 2019
2017Mar 9, 2018
2016Mar 3, 2017
2015Mar 4, 2016

About Earnings Per Share Disclosures

The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.

Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.